Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06278987 · ClinicalTrials.gov registry record · Phase 4

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture

A Phase 4 study of Hip Fractures, sponsored by University of Minnesota.

Recruiting
Registry status
Phase 4
Development phase
150
Enrollment target
1
Study location

NCT06278987 is a Phase 4 study of Hip Fractures that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 150 participants, below the 611-participant average among 15 other Hip Fractures trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06278987, a Phase 4 study of Hip Fractures, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
Phase 4
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.

Conditions Studied

Interventions

  • DRUG PENG block and cryoablation
  • DRUG fascia iliaca compartment block

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2024-10-01
Est. Completion 2027-10-01
Phase Phase 4

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT06278987

The ClinicalTrials.gov registry entry for NCT06278987 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 611-participant average among 15 other Hip Fractures trials with a reported enrollment target (75% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hip Fractures appearing as the primary indexed condition, and to 2 interventions - of which PENG block and cryoablation is the first listed.

NCT06278987 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06278987 about?

NCT06278987 is a clinical study titled "Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture". The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.

What is the current status of trial NCT06278987?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2024-10-01. Estimated completion is 2027-10-01.

What conditions does trial NCT06278987 study?

This clinical trial studies the following conditions: Hip Fractures.

What interventions are being tested in trial NCT06278987?

The interventions under investigation include: PENG block and cryoablation (DRUG), fascia iliaca compartment block (DRUG).

Who is sponsoring clinical trial NCT06278987?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06278987 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.